- Home
- TXRH vs BMRN Comparison
TXRH vs BMRN Comparison
Compare TXRH & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXRH
- BMRN
- Stock Information
- Founded
- TXRH 1993
- BMRN 1996
- Country
- TXRH United States
- BMRN United States
- Employees
- TXRH N/A
- BMRN N/A
- Industry
- TXRH Restaurants
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- TXRH Consumer Discretionary
- BMRN Health Care
- Exchange
- TXRH Nasdaq
- BMRN Nasdaq
- Market Cap
- TXRH 10.9B
- BMRN 10.0B
- IPO Year
- TXRH 2004
- BMRN 1999
- Fundamental
- Price
- TXRH $164.90
- BMRN $51.52
- Analyst Decision
- TXRH Buy
- BMRN Buy
- Analyst Count
- TXRH 17
- BMRN 19
- Target Price
- TXRH $189.47
- BMRN $90.26
- AVG Volume (30 Days)
- TXRH 1.2M
- BMRN 2.8M
- Earning Date
- TXRH 11-06-2025
- BMRN 10-27-2025
- Dividend Yield
- TXRH 1.65%
- BMRN N/A
- EPS Growth
- TXRH 12.56
- BMRN 59.53
- EPS
- TXRH 6.55
- BMRN 2.68
- Revenue
- TXRH $5,833,958,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- TXRH $11.74
- BMRN $13.32
- Revenue Next Year
- TXRH $10.04
- BMRN $7.51
- P/E Ratio
- TXRH $25.19
- BMRN $19.20
- Revenue Growth
- TXRH 14.40
- BMRN 12.39
- 52 Week Low
- TXRH $148.73
- BMRN $50.76
- 52 Week High
- TXRH $206.04
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- TXRH 42.69
- BMRN 40.53
- Support Level
- TXRH $159.00
- BMRN $51.80
- Resistance Level
- TXRH $167.02
- BMRN $53.49
- Average True Range (ATR)
- TXRH 4.19
- BMRN 1.84
- MACD
- TXRH -1.19
- BMRN -0.08
- Stochastic Oscillator
- TXRH 32.72
- BMRN 12.58
About TXRH Texas Roadhouse Inc.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.